Literature DB >> 15914680

The efficacy of sonographically indicated cerclage in multiple gestations.

Ashley S Roman1, Andrei Rebarber, Leonardo Pereira, Anna K Sfakianaki, Jeanine Mulholland, Vincenzo Berghella.   

Abstract

OBJECTIVE: The purpose of this study was to determine the efficacy of sonographically indicated cerclage in multiple gestations with sonographic evidence of short cervical length (CL).
METHODS: Between 1996 and 2002, all multiple gestations undergoing serial CL determinations in the second trimester were identified in 2 separate institutions. Cervical lengths were measured sonographically with transvaginal probes (4-8 MHz). Short CL was defined as a closed CL of 2.5 cm or less. When a short CL was identified before 24 weeks, the study group underwent sonographically indicated cerclage via the modified Shirodkar technique; control patients were placed on bed rest without surgical intervention. The primary outcome was incidence of spontaneous preterm birth before 32 weeks. The groups were compared with the Mann-Whitney U test and the Fisher exact test, with a 2-sided P<.05 used to define statistical significance. Odds ratios were calculated, and 95% confidence intervals were reported.
RESULTS: A total of 414 sets of twin gestations and 92 sets of triplet gestations were identified. The median gestational age at delivery for twin gestations was 34.0 weeks for patients who received cervical cerclage and 34.4 weeks for patients with short cervix and no cerclage (P=.77). The median gestational age at delivery for triplet gestations was 34.1 weeks for patients who received cervical cerclage and 33.0 weeks for patients with short cervix and no cerclage (P=.21). There was no difference in the rate of spontaneous preterm delivery at fewer than 28, 30, 32, and 34 weeks or in the rate of preterm premature ruptured membranes.
CONCLUSIONS: In our study of multiple gestations with short CL, sonographically indicated cerclage was not associated with a lower incidence of spontaneous preterm delivery compared with conservative management.

Entities:  

Mesh:

Year:  2005        PMID: 15914680     DOI: 10.7863/jum.2005.24.6.763

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

1.  Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate.

Authors:  Celeste P Durnwald; Valerija Momirova; Dwight J Rouse; Steve N Caritis; Alan M Peaceman; Anthony Sciscione; Michael W Varner; Fergal D Malone; Brian M Mercer; John M Thorp; Yoram Sorokin; Marshall W Carpenter; Julie Lo; Susan M Ramin; Margaret Harper; Catherine Y Spong
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-04

2.  The impact of cerclage in twin pregnancies on preterm birth rate before 32 weeks.

Authors:  Michelle N Han; Betsy E O'Donnell; Melanie M Maykin; Juan M Gonzalez; Khalil Tabsh; Stephanie L Gaw
Journal:  J Matern Fetal Neonatal Med       Date:  2018-01-23

3.  Elective and emergency cervical cerclage and immediate pregnancy outcomes: a retrospective observational study.

Authors:  Andrea Liddiard; Sohinee Bhattacharya; Lena Crichton
Journal:  JRSM Short Rep       Date:  2011-11-28

4.  Development and evaluating multimarker models for guiding treatment decisions.

Authors:  Parvin Tajik; Mohammad Hadi Zafarmand; Aeilko H Zwinderman; Ben W Mol; Patrick M Bossuyt
Journal:  BMC Med Inform Decis Mak       Date:  2018-06-28       Impact factor: 2.796

5.  Effects of emergency cerclage on the neonatal outcomes of preterm twin pregnancies compared to preterm singleton pregnancies: A neonatal focus.

Authors:  Sang Hoon Chun; Jiyoung Chun; Keun-Young Lee; Tae-Jung Sung
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

6.  Emergency cerclage placement in multifetal pregnancies with a dilated cervix and exposed membranes: case series.

Authors:  Marijo Aguilera; Kirk Ramin; Ruby Nguyen; Lauren Giacobbe; Jessica Swartout
Journal:  AJP Rep       Date:  2012-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.